Workflow
聚氨酯制品
icon
Search documents
华峰化学(002064):持续筑底,拐点或现
Changjiang Securities· 2025-10-29 09:42
Investment Rating - The investment rating for the company is "Buy" and it is maintained [9] Core Views - The company reported a revenue of 18.11 billion yuan for the first three quarters of 2025, a year-on-year decrease of 11.1%, and a net profit attributable to shareholders of 1.46 billion yuan, down 27.5% year-on-year [2][6] - In Q3 alone, the company achieved a revenue of 5.97 billion yuan, a year-on-year decline of 9.9% but a quarter-on-quarter increase of 2.6% [2][6] - The company is a leader in the polyurethane products industry in China, focusing on spandex, adipic acid, and polyurethane raw materials, with significant production capacities [12] - The spandex prices have hit new lows, and the adipic acid market is at a cyclical low, with various product price changes reported for Q3 2025 [12] - The company has maintained high R&D investment, with a R&D expense ratio of 3.7% for Q1 to Q3 2025, indicating a commitment to technological advancement in the industry [12] - The company is actively fulfilling its social responsibility by donating 500 million yuan to support educational development in Zhejiang Province [12] Financial Summary - For the fiscal year 2025, the company is projected to have a net profit of 1.75 billion yuan, with estimates of 2.52 billion yuan and 3.17 billion yuan for 2026 and 2027 respectively [12][17] - The company’s gross margin for Q3 2025 was reported at 14.7%, showing a quarter-on-quarter increase of 0.6 percentage points [12] - The company’s total revenue is expected to be 25.46 billion yuan in 2025, with a slight increase to 27.63 billion yuan in 2026 [17]
华峰化学(002064):逆境降本,景气底部见业绩韧性
Changjiang Securities· 2025-08-13 13:11
Investment Rating - The investment rating for the company is "Buy" and it is maintained [10]. Core Viewpoints - The company reported a revenue of 12.14 billion yuan for the first half of 2025, a year-on-year decrease of 11.7%. The net profit attributable to shareholders was 980 million yuan, down 35.2% year-on-year, and the net profit after deducting non-recurring gains and losses was 900 million yuan, down 37.8% year-on-year. In Q2 alone, the revenue was 5.82 billion yuan, a year-on-year decrease of 17.8% and a quarter-on-quarter decrease of 7.8%. The net profit for Q2 was 480 million yuan, down 42.6% year-on-year and 5.0% quarter-on-quarter, with a net profit after deducting non-recurring gains and losses of 440 million yuan, down 44.3% year-on-year and 3.3% quarter-on-quarter [2][7]. Summary by Relevant Sections Financial Performance - The company achieved a gross margin of 14.1% in Q2 2025, an increase of 0.6 percentage points quarter-on-quarter, and a net margin of 8.3%, up 0.3 percentage points quarter-on-quarter. The average price difference for spandex in H1 2025 was approximately 10,812 yuan per ton, narrowing by 1,307 yuan per ton compared to H1 2024. The spandex gross margin improved from 15.0% in H1 2024 to 18.6% in H1 2025, indicating strong cost control capabilities [13][13]. Market Outlook - The profitability of adipic acid is under short-term pressure but remains promising in the long term. The domestic market for adipic acid is maturing with intense competition, and the industry is undergoing consolidation. However, with the gradual recovery of the economic environment and supportive policies, downstream demand is expected to increase, particularly in nylon and TPU production, which will drive growth in adipic acid consumption [13][13]. Strategic Developments - The major shareholder's asset injection will continue, with the commitment period extended to December 2026. This will further expand the industry chain and enhance the company's core competitiveness. The company is focused on spandex, polyurethane raw materials, and adipic acid, positioning itself as a leader in the polyurethane products industry [13][13]. Future Profit Forecast - The company is expected to achieve net profits attributable to shareholders of 1.97 billion yuan, 2.76 billion yuan, and 3.33 billion yuan for the years 2025, 2026, and 2027, respectively [13].